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Abstract 
Antisense oligonucleotides (ODN), complementary to mRNA of human tumor necrosis factor a (TNFa) and lymphotoxin (LT) were 
tested for their ability to inhibit TNFs. TNFs production was studied in cell-free systems including wheat germ extract (WGE) and rabbit 
reticulocyte lysate (RRL). All ODN were effective in WGE at low concentration (0.2 /xM), except hose targeted to the 3' region of 
TNFa mRNA. A short ODN complementary to a common region between TNFa and LT inhibited both TNFs. In contrast, high ODN 
concentration (50 /xM) was needed to inhibit LT mRNA translation in RRL, whereas no clear inhibition of TNFa was observed unless 
RNase H was added to the translation mixture. ODN effects on TNFs production by stimulated cell line in culture were also investigated. 
Three ODN - -  one located in the Y-untranslated region, one spanning the AUG initiation codon and one downstream of this AUG - -  
were the most effective sequences todecrease TNFa production. Two ODN targeted to the AUG initiation codon of LT were also able to 
inhibit its production. In conclusion we confirm the role of RNase H in cell free systems, and we found that there is no correlation 
between ODN efficiency in a cell-free system nor in cell culture. Efficient ODN could be used for in vitro investigation of the role of 
TNFa and LT in mechanism in which they are involved. 
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1. Introduction 
Tumor necrosis factor a (TNFa) and lymphotoxin or 
tumor necrosis factor /3 (LT, LTa,  or TNF/3) are two 
closely related cytokines involved in many regulatory ac- 
tivities [1,2]. Almost all cells of the immune system (in- 
cluding macrophages, B and T lymphocytes, natural killer 
cells, and mast cells) and cells that are not part of the 
immune system (e.g., smooth muscle cells, astrocytes, 
granulosa cells, epithelial cells, breast and ovarian tumor 
cells) can produce TNFa [3]. LT, in contrast, is mainly 
secreted by lymphocytes [4]. TNFa and LT are each 
Abbreviations: TNF, tumor necrosis factor; LT, lymphotoxin; PMA, 
phorbol 12-myristate 13-acetate; PHA, phytohemagglutinin; ODN, anti- 
sense oligonucleotides; ELISA, enzyme-linked immunosorbent assay; 
BMV, brome mosaic virus; WGE, wheat germ extract; RRL, rabbit 
reticulocyte lysate; FCS, fetal calf serum; SDS-PAGE, sodium dodecyl 
sulfate-polyacrylamide g l electrophoresis; TCA, trichloroacetic a id 
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encoded by unique genes and share approximately 30 
percent amino acid homology [5]. They have very similar 
but not identical biological activities [6]. 
In a number of pathology such as septic shock, rheuma- 
toid arthritis, allograft rejection, parasitic diseases, 
meningococcal disease and AIDS a high level of TNFa is 
released in the plasma [7]. TNFa and LT are involved in 
inflammatory processes, in pathologies like multiple scle- 
rosis or AIDS dementia [8-11], and may also induce 
proliferation as autocrine growth factor for B cell lines 
[12-14] and for cytotrophoblastic cell [15]. 
Thus it may be of interest o develop specific inhibitor 
of TNFs to investigate their role in such disorders and to 
propose new therapies; this can be achieved by antisense 
strategy. Antisense oligodeoxyribonucleotides (ODN) have 
been used to block translation of protein in cell-free sys- 
tems, in cultured cells, and in vivo [16,17]. Numerous 
studies demonstrate the regulation of cytokine production 
by this methodology [18], but to our knowledge ODN have 
neither yet been applied to regulate TNFa and LT produc- 
tion in cell-free systems, nor to regulate LT in cell culture. 
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Fig. 1. Schematic illustration of location of the oligonucleotides. 
Coding region 
In the present study, the action of different ODN on the 
synthesis of TNFc~ and LT was investigated, both in cell 
free system and in cell culture. The importance of RNase 
H was confirmed in cell free extract and the possibility to 
predict AS efficiency in cell culture, by calculated sec- 
ondary structure or by using cell free extract was also 
studied. 
2. Materials and methods 
washed with 75% ethanol, and reconstituted in water. An 
aliquot of each sample was labelled at the 5'-end using T4 
polynucleotide kinase and [32p]ATP and analysed for ho- 
mogeneity on a 20% polyacrylamide gel. Concentration of 
oligonucleotide solution was determined spectrophotomet- 
rically. Schematic localization and sequence of oligo- 
nucleotide are shown in Fig. 1 and in Table 1. ODN T180, 
T183 and T188 have been previously described [12,19,20]. 
Position 183 to 185 and 81 to 83 correspond to the AUG 
codon of human TNFc~ and LT respectively. 
2.1. Reagents 
Phorbol 12-myristate 13-acetate (PMA), phytohemag- 
glutinin (PHA-M), and calcium ionophore A23187 were 
purchased from Sigma Chemicals (Saint Quentin FaUavier, 
France) and used at 10 ng/ml, 10 /xg/ml and 0.5 /xM, 
respectively. 
2.2. Oligonucleotides 
Unmodified oligonucleotides were synthesized by 
Genset (Paris, France) on an automated solid-phase synthe- 
sizer (Applied Biosystems) using phosphoramidite chem- 
istry. Oligonucleotides were ethanol precipitated twice, 
2.3. Plasmids 
The construction PSP65-hTNF1 containing the TNF~ 
cDNA in SP6 orientation was obtained from the Labora- 
tory of molecular biology-plasmid collection University of 
Gent [21]. LT cDNA clone LT#11 is a generous gift from 
N. Matsuyama [22]. The EcoRI fragment of LT#11 was 
subcloned into pGEM4Z plasmid (Promega, Charbonni~res, 
France). The construction containing LT cDNA in a SP6 
orientation was designated pGEM4Z-hLT1. 
2.4. In vitro synthesis of capped transcripts 
Plasmids pSP65-hTNF1 and pGEM4Z-hLT1 linearized, 
respectively, at the unique NcoI site and HindlII, were 
Table 1 
Sequence of oligonucleotides 
Oligonucleotide Length Sequence (5' --, 3') Target site Target 
T002 l 8 GAGGGAGCGTCTGCTGGC 5'-untranslated 
T027 18 TAGCTGGTCCTCTGCTGT 5'-untranslated 
T052 18 GGTCTGTAGTrGCTTCTC 5'-untranslated 
T077 18 GCGTCTGAGGGTTGI-ITI 5'-untranslated 
T 102 18 GCCTGGCAGCTTGTCAGG 5'-untranslated 
T 127 18 TCAGTATGTGAGAGGAAG 5'-untranslated 
T152 18 AGGGGAGAGAGGGTGAAG 5'-untranslated 
T168 * 18 TCATGGTGTCCTTTCCAG AUG codon 
T180 15 TTCAGTGCTCATGGT AUG codon 
T183 * 18 CATGCTTTCAGTGCTCAT AUG codon 
T187 15 TCATGC I I ICAGTGC coding region E 1 
T 188 17 GGATCATGCTTI'CAGTG coding region E 1 
T 195 18 CCACGTCCCGGATCATGC coding region E 1 
AB * 13 ACCTGGGAGTAGA coding region E4 
T920 18 ATI'GGGGCAGGGGAGGCG 3' untranslated 
L066 18 CA TGGGGAGAACCCAGGC AUG codon 
L081 18 ACGT'I'CAGGTGGTGTCA T AUG codon 
MT * 20 TCATGGTGTCTITrCTGGAG AUG codon 
hTNFa 
hTNFa 
hTNFot 
hTNFa 
hTNFa 
hTNFo~ 
hTNFa 
hTNFot 
hTNFa 
hTNFot 
hTNFot 
hTNFa 
hTNFct 
hTNFot/hLT 
hTNFa 
hLT 
hLT 
mTNFt~ 
Underlining indicates sequence complementary to the initiation codon. El, exon 1; E,4, exon 4; h, human; m, murin. * Sense and/or random sequence of 
these oligonucleotide were also synthesized and used as control. 
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used as a template for run-off transcription. In vitro tran- 
scription was carried out essentially as recommended by 
the supplier (Promega). Briefly 5 /zg of linearized plasmid 
were transcribe in 10/~1 of 5 × buffer (200 mM Tris-HC1, 
pH 7.5; 30 mM MgC12; 10 mM spermidine; 50 mM 
NaC1), 50 U of RNasin TM, 0.5 A260 units of 
m7(GS)ppp(5')G cap structure (Boerhinger Mannheim, 
Meylan, France), 250 /zM GTP, 500 /zM of the 3 other 
NTPs (Promega) and 40 U of SP6 polymerase. After 1 h at 
37°C, the mixture was incubated with DNase I 15 min at 
37°C and was phenol-chloroform extracted. Unincorpo- 
rated nucleotides were removed by Sephadex G-50 
columms (Boehringer Mannheim). 
2.5. Translation in cell-free system 
Nuclease-treated wheat germ extract (WGE) and rabbit 
reticulocyte lysate (RRL) were purchased from Promega. 
Cell-free translation was carried out essentially as recom- 
mended by the supplier. 70 ng of in vitro synthesized 
capped transcript solution was used per 10 /~1 of transla- 
tional mixture, and 0.150 MBq of [35S]methionine (37 
TBq/mmol, Amersham, Les Ulis, France) was used for 
labelling. Brome mosaic virus (BMV) RNA was used as 
control of translation. The reaction was run 1 h at 25°C for 
WGE and 1 h at 30°C for RRL. The 35S-labelled transla- 
tion products were analyzed either by trichloroacetic acid 
(TCA) precipitation [23] or by electrophoretic separation 
on 15% SDS-polyacrylamide slab gels (SDS-PAGE) [24], 
and autoradiography. Autoradiographs were quantified us- 
ing laser densitometry. 
2.6. Cell culture 
Lymphoblastic T (Jurkat) and monocytic (U937) cell 
lines were maintained in RPMI 1640 supplemented with 
L-glutamine, penicillin-streptomycin and 10% heat inacti- 
vated fetal calf serum (FCS) (Gibco BRL, Eragny, France). 
After three washes, cells were resuspended at 5 × 104 cells 
in 0.1 ml of culture medium and plated in 96 well plates. 
Various concentrations of oligonucleotide (5 /zM-100 
/xM) were added for a 4-h incubation period, stimuli were 
then added, and the cells reincubated at 37°C and in 5% 
CO 2. Supernatants were collected after 6 h and 24 h for 
U937 and Jurkat culture respectively and stored at -80°C 
until assayed for cytokine production. Cell viability was 
monitored by trypan blue exclusion. 
2.7. TNFs detection 
TNF assays were performed using the sensitive L929 
cells as describe by Fish and Gifford [25]. Briefly, 5 × 10 4 
L-929 cells/well suspended in 0.1 ml RPMI 1640 contain- 
ing 10% FCS were seeded in 96-well microtitre plates. 
Actinomycin D (Sigma) at 4 /xg/ml final concentration 
was added prior to the addition of the sample dilutions (0.1 
ml). The cells were then incubated at 37°C for 18 h, and 
extensively washed afterwards in Hanks' balanced salt 
solution. The remaining adherent cells were stained for 10 
min with crystal violet (0.2% in 2% ethanol), washed with 
water and 0,1 ml of 1% SDS was added to each well to 
solubilize the stained cells. The absorbance of each well 
was read at 550 nm. The percentage of cytotoxicity was 
defined as the relative absorbance of the tested sample 
versus the absorbance of the control (medium only) wells. 
( absorbance samples ) 
%cytotoxicity = 1 - absorbance control × 100 
The cytotoxicity titer (U/ml) was defined as the recip- 
rocal dilution of the test sample inducing 50% of cytotoxi- 
city. Recombinant TNF was used as a positive control. 
In some experiments, the level of TNFa and LT were 
determined alternatively by using commercialized kits. 
TNFa ELISA was purchased from Medgenix (Fleurus, 
Belgium) and LT ELISA was purchased from R&D Sys- 
tems Europe (Abingdon, UK). 
3. Results 
3.1. Effects of  oligonucleotides on TNFs translation in 
cell-free extracts 
3.1.1. Translation in wheat germ extract 
In vitro synthesized, capped transcripts of human TNF 
or/and human LT were translated in WGE in the presence 
or absence of oligonucleotides. We found that ODN tar- 
geted to the 5', AUG, or coding region successfully ar- 
rested translation of TNFa, whereas an ODN in the 3' 
untranslated region (ODN T920) and control sequences 
(ODN T168S, ABS and MTS) had no inhibitory effects. 
Furthermore, ODN in the AUG region of LT (ODN L066 
and L081) were also effective at inhibiting LT translation. 
All inhibitory ODN displayed similar efficiency and about 
0.2 /xM led to a 50% decrease of translation as determined 
by TCA precipitation and SDS-PAGE (Fig. 2A). Inhibition 
of translation was specific, because when the two RNA 
were co-translated in presence of ODN it was possible to 
inhibit one of them without modifying the other (at 0.5 and 
1 /xM) (Fig. 2B). We also tested a short ODN (ODN AB) 
which is common to TNFa and LT; we observed that both 
TNFs were inhibited (at 1 and 5 /zM), whereas the sense 
sequence (ABS) or an unrelated sequence (MTS) had no 
effect on TNFs translation (Fig. 3). 
3.1.2. Translation in rabbit reticulocyte lysate 
The effects of ODN on translation of TNFa in RRL 
were variable, and no significant inhibition was observed 
until addition of RNase H (20 U/ml)  in the reaction 
mixture as previously described [26]. Thus, after RNase H 
addition, a similar pattern as in WGE was obtained, and 
the dose of ODN necessary for 50% of inhibition (ID 
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Fig. 2. Inhibition of TNFa and LT translation in WGE. Samples were analysed on SDS-PAGE and autoradiographed as indicated inSection 2. A: Lane 1 : 
rio RNA, lane 2: BMV mRNA, lane 3: LT mRNA, lane 4-6: LT mRNA + ODN L081 at 0.1 txM (lane 4), 0.5 /xM (lane 5) and 1 txM (lane 6), lane 7: 
TNFa mRNA, lane 8-10: TNFa mRNA + ODN T168 at 0.1 txM (lane 8), 0.5 ~M (lane 9) and 1 /xM (lane 10). Similar inhibition of translation was 
observed with ODN T102, T127, T152, T168, T180, T183, T187, T188, T195 for TNFa and with L066 for LT. Densitometry was expressed aspercent 
control (lane 3 for LT and lane 7 for TNFo~). B: Lane 1: no RNA, lane 2: BMV mRNA, lane 3: LT and TNFa mRNA, lane 4-6: LT and TNFa 
mRNA + ODN L081 at 0.1 NM (lane 4), 0.5 txM (lane 5) and 1 IxM (lane 6), lane 7-9: LT and TNFa mRNA + ODN T168 at 0.1 ~M (lane 7), 0.5 IxM 
(lane 8) and 1 ~M (lane 9). Densitometry was expressed aspercent control ( ane 3). Typical autoradiograph representative of three different experiments. 
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Fig. 3. Inhibition of both TNFs translation in WGE. Lane 1, no RNA; 
lane 2, BMV mRNA; lane 3, LT mRNA; lane 4, TNFa mRNA; lane 5, 
LT and TNFa mRNA; lane 6-9, LT and TNFa mRNA+ODN AB at 
0.1 /~M (lane 6); 0.5 /xM (lane 7); 1 /xM (lane 8) and 5 /zM (lane 9); 
lanes 10-13, LT and TNFa mRNA+ODN ABS at 0.1 /xM (lane 10); 
0.5 /zM (lane 11); 1 /xM (lane 12) and 5 /~M (lane 13); lane 14, LT and 
TNFa mRNA + ODN MTS at 5/xM. AB is a short ODN complementary 
to TNFot and LT. ABS is the corresponding sense ODN. MTS is an 
unrelevant oligonucleotide (sense sequence of MT). Densitometry was 
expressed as percent control (lanes 3, 4 and 5). Typical autoradiograph 
representative of three different experiments. 
50%) was also about 0.2 /xM (Fig. 4B). Besides, we found 
a difference with LT; its production was inhibited by both 
LT ODN at high concentration (20-80 /zM) even without 
RNase H addition, and ID 50% was about 40/xM (Fig. 
4A). This LT inhibition did not result from a general effect 
on in vitro translation, as these ODNs did not induce any 
decrease of BMV protein synthesis at ODN concentrations 
up to 80 /zM (Fig. 4A). 
3.2. Effects of oligonucleotides on stimulated cells 
Serum presence in culture media was described as being 
a major source of oligonucleotide degradation [27]. When 
the serum was heat inactivated 30 min at 56°C, oligo- 
nucleotide was rapidly degraded and no more intact oligo- 
nucleotide remained after 4 h of incubation at 37°C. In 
contrast, heat inactivation of FCS for 1 h at 65°C sup- 
pressed nuclease activity, and oligonucleotide were stable 
up to 48 h (data not shown). In all cell culture experi- 
ments, medium was supplemented with FCS which has 
been heat inactivated for 1 h at 65°C. 
Two cell lines were chosen in order to study TNFa and 
LT production in presence of ODN. We found that at least 
three TNFa ODN and two LT ODN had an inhibitory 
activity. 
On the one hand, U937 which is a monocytic ell line 
produced TNFa when stimulated with PMA + calcium 
ionophore. An ODN located in the 5'-untranslated region 
(ODN T027), another surrounding the initiating AUG 
(ODN T180) and ODN T195 which is in the coding 
172 C. Lefebvre d'Hellencourt et al. /Biochimica et Biophysica Acta 1317 (1996) 168-174 
100 
75 
50 
25 
100 - 
A 
10 20 40 80 
ODN concentration (I.tM) 
75 
50 
25- 
O 
i 
0.1 0.5 1 5 10 
.= 
.=, 
ODN concentration (I.tM) 
Fig. 4. Inhibition of TNFa and LT translation in RRL (A) and in RRL 
with RNase H (B). Percentage of inhibition was determined from TCA 
precipitations and counting. Percentage of inhibition of TNFa in the 
presence of ODN T168 (A), of LT in the presence of ODN L081 (O) 
and of BMV in the presence of ODN L081 (©). One representative 
experiments out of three identically performed experiments is shown. 
region, were most effective in inhibiting the TNFa pro- 
duction (55 to 75% of inhibition at 40/zM). ODN targeted 
to the 5' region (ODN T002 and T102), spanning the AUG 
region (ODN T168 and T183), or in the coding region 
(T188) were also effective, but exhibited a less pronounced 
activity (30 to 45% at 40/xM). At least, the other ODN in 
5' region (ODN T052, T077), one just downstream AUG 
(ODN T187), one in the 3' region (ODN T920) and control 
oligonucleotides induced only slight modification i  TNFa 
release (< 25% inhibition at 40 IzM) (Fig. 5A). 
On the other hand, the T cell line Jurkat produced LT 
when stimulated with PMA + PHA. Two ODN located in 
the translation i itiation codon were tested. ODN L066 and 
ODN L081 were both effective in LT inhibition (65 to 
75% of inhibition at 100 /xM), whereas control sequence 
had no effect ( < 20% of inhibition at 100 /zM) (Fig. 5B). 
It should be noted that as it was previously described 
for collagen [28], we found that there was variation in the 
values obtained with the same ODN. 
4. D iscuss ion  
In this study, we firstly investigated ODN effects on 
TNFa and LT production in cell free systems. In order to 
assess the role of RNase H we used in vitro translation 
systems with either a high or low RNase H activity. In 
WGE all the ODN in the coding or in the 5' leader egion 
had a similar inhibition efficiency, probably due to the 
high RNase H activity. Indeed in RRL, which has a poor 
RNase H activity, none of the ODN gave a significative 
inhibition of TNFa, unless RNase H was added. Con- 
versely, a decrease of LT production in RRL was achieved 
with ODN even without addition of RNase H, but with 
higher ODN concentration than in presence of RNase H. 
This is in agreement with a report in which globin was 
entirely inhibited by 100 /zM of ODN in RRL [29]. 
However the reason for the difference between ODN 
efficiency on TNFa and LT production in RRL remain 
unclear, but could be partly due to differences in the 
secondary (or even tertiary) structure of LT and TNF RNA 
in the translational mixture and thus differences in accessi- 
bility. 
100 [] 10uM [] 25BM 
] 120uM A l II 50l.tM B1 
8o t .4ou. i 
~ 4o 
2 
Fig. 5. ODN Inhibition of TNFa and LT production by stimulated cells. The experiment was performed as explained in Section 2. A. ODN inhibition of 
TNFa release by stimulated U937 cells. ODN were added for a 4-h incubation period, PMA + calcium ionophore were then added, and the cells 
reincubated for a 6-h period. B. ODN inhibition of LT release by stimulated Jurkat cells. ODN were added for a 4-h incubation period, PMA + PHA were 
then added, and the ceils reincubated for a 24-h period. Each value represents he mean of three separate xperiments + SEM. 
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We also investigated ODN efficiency at cellular level. 
Among the panel of ODN tested (Fig. 1), we obtained 
different results depending on the localization. For TNFa, 
one ODN located ownstream of the AUG initiation codon, 
another one spanning the translation initiation codon and 
one more in the 5'-untranslated region were the most 
efficient to inhibit this cytokine production. Furthermore, 
three sequences used in this work have been previously 
described for inhibiting TNFa in non tumorigen human B 
cells (ODN T180) [12], in LPS stimulated monocytes 
(T183) [19] and in cytotrophoblastic cells (ODN T188) 
[20]. In our model only T180 ODN show an important 
inhibitory activity, while the two others were less efficient. 
The difference of the cellular type used in these studies 
were probably responsible for the discrepancies of ODN 
efficiency. Antisense stategy have also been used to 
demonstrate an autocrine growth regulator activity of TNFa 
in a murine culture of bone marrow cells [30]. Concerning 
LT, two ODN spanning the translation initiation codon 
were tested for their ability to inhibit this protein release 
by stimulated Jurkat cells. Both of them inhibited LT 
production, but a higher ODN concentration than for TNFa 
was needed to observe an inhibition. This is consistent 
with a recent report in which, interferon Y, another cy- 
tokine produced by T lymphocyte was inhibited by spe- 
cific ODN at concentration up to 250 /xM [31]. 
The TNF production were monitored by a TNF bioas- 
say using L929 cells sensitized by actinomycin D. It has 
been recently reported that oligonucleotide could interact 
with actinomycin D without sequence specificity and leads 
to a protective effect [32]. However in our hand, the 
addition of oligonucleotide (up to 200 /zM) in known 
concentration of TNF did not modify the response of L929 
(data not shown). This can be explain by the use of a 
higher concentration of actinomycin D (4 /zg/ml vs. 1 
/xg/ml). Furthermore some supernatant of ODN treated 
cells were also tested in ELISA, and in these experiments 
the percentage of inhibition were comparable with the 
bioassay result (data not shown). 
It is difficult to predict ODN efficiency, even if sec- 
ondary structure of RNA may be calculated [33]. Some 
results supported the hypothesis that single-stranded loop 
structures were more promising targets for ODN than 
double-stranded sequences [34,35]. In contrast, for TNFa, 
we found no apparent correlation between ODN efficacy 
and predicted mRNA secondary structure. This is in agree- 
ment with a recent report concerning inhibition of human 
collagen by ODN [28]. The two LT ODN we had tested 
were essentially targeted to a calculated single strand loop 
structure, and thus it is not possible to conclude on a 
relation between structure and efficiency for LT. 
Our results demonstrate hat it was possible to inhibit 
both TNFs with a unique ODN in cell free systems, 
however before use of this TNFa/LT  ODN in cell culture 
or in vivo, and because of its short size (13 bases), it 
would be probably necessary to increase affinity of 
TNFa/LT  ODN by modification, like 2' O-al- 
kyloligoribonucleotides. 
We can also conclude that there is no correlation be- 
tween the predicted secondary structure of RNA, ODN 
efficiency in cell free extract, and ODN efficiency in cell 
culture. However, it is likely that cell-free production of 
TNFs could be of interest o evaluate new ODN modifica- 
tion, in a simple way. Moreover ODN showing an in- 
hibitory activity could be used to study in vitro further the 
role of TNFs in pathological situations or in immunologi- 
cal mechanisms. 
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